Select a Region North America



Senior Vice President


Consulting (Strategy Management & Regulatory), Digital Health, Digital Medicine, Digital Technology, HEOR, Managed Markets, Market Access, Market Research

With more than 20 years of healthcare experience, including consulting and industry roles, Amar has focused on commercial assessment, forecasting, pricing and access, commercial excellence, portfolio planning and strategic market research.

Amar’s expertise includes market and commercial assessment, partnering and out-licensing of biologics, valuation of assets for out-licensing to foreign markets, commercial due diligence and valuation of assets for acquisition.

Amar is a Pharmacy graduate with an MBA from the Indian Institute of Management, Calcutta.

Articles by アマディープ・ウデシ

Doing the Right Things Right: A Perspective on Rare Disease Drug Development

Millions of patients with rare diseases have benefited from the emphasis biopharmaceutical companies have put on the development of orphan drugs over the last decades. The more patients served, the more complex and challenging it becomes, requiring pharmaceutical companies and other healthcare stakeholders to work collaboratively to ensure patients have access to innovative rare disease treatments.   In this insightful presentation, Amardeep Udeshi, Principal, EVERSANA APAC, provides his views and perspective on rare disease drug development. Watch the full presentation:

Interested in scheduling a meeting or speaking event?